Subtopic Deep Dive
Male Circumcision HIV Prevention Trials
Research Guide
What is Male Circumcision HIV Prevention Trials?
Male Circumcision HIV Prevention Trials are randomized controlled trials evaluating male circumcision's efficacy in reducing heterosexual HIV acquisition risk, primarily through the ANRS 1265 and Kisumu studies.
These trials, including Auvert et al. (2005) with 2437 citations, demonstrated 60% protection against HIV infection in South Africa. Kisumu cohort studies confirmed similar efficacy without risk compensation (Mattson et al., 2008). Over 20 trials and modeling studies support voluntary medical male circumcision (VMMC) scale-up in sub-Saharan Africa.
Why It Matters
ANRS 1265 trial results (Auvert et al., 2005) informed WHO/UNAIDS 2007 guidelines recommending VMMC in high-prevalence areas, averting millions of infections. Modeling by Njeuhmeli et al. (2011, 324 citations) showed net savings from scale-up in eastern/southern Africa. Weiss et al. (2010, 380 citations) systematic review established low complication rates, enabling safe public health rollout.
Key Research Challenges
Risk Compensation Assessment
Trials must verify no increased risky behavior post-circumcision. Mattson et al. (2008) multi-faceted assessment in Kisumu found no risk compensation in RCT participants. Ongoing monitoring needed as VMMC scales.
Complication Rates in Scale-Up
Adverse events rise with traditional providers or non-sterile settings. Bailey (2008) prospective study in Bungoma reported higher complications in traditional vs. clinical circumcision. Weiss et al. (2010) review highlighted risks at older ages.
Implementation Cost Modeling
Economic impact requires accurate HIV incidence projections. Njeuhmeli et al. (2011) modeled VMMC expansion costs and savings across Africa. Hankins (2009) reviewed models for decision-making in high-prevalence settings.
Essential Papers
Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 Trial
Bertran Auvert, Dirk Taljaard, Emmanuel Lagarde et al. · 2005 · PLoS Medicine · 2.4K citations
Male circumcision provides a degree of protection against acquiring HIV infection, equivalent to what a vaccine of high efficacy would have achieved. Male circumcision may provide an important way ...
Complications of circumcision in male neonates, infants and children: a systematic review
Helen A. Weiss, Natasha Larke, Daniel T. Halperin et al. · 2010 · BMC Urology · 380 citations
Studies report few severe complications following circumcision. However, mild or moderate complications are seen, especially when circumcision is undertaken at older ages, by inexperienced provider...
Acceptability of Male Circumcision for Prevention of HIV/AIDS in Sub-Saharan Africa: A Review
Nelli Westercamp, Robin L. Bailey · 2006 · AIDS and Behavior · 376 citations
Voluntary Medical Male Circumcision: Modeling the Impact and Cost of Expanding Male Circumcision for HIV Prevention in Eastern and Southern Africa
Emmanuel Njeuhmeli, Steven Forsythe, Jason Reed et al. · 2011 · PLoS Medicine · 324 citations
This study suggests that rapid scale-up of VMMC in eastern and southern Africa is warranted based on the likely impact on the region's HIV epidemics and net savings. Scaling up of safe VMMC in east...
Male circumcision, religion, and infectious diseases: an ecologic analysis of 118 developing countries
Paul K. Drain, Daniel T. Halperin, James P. Hughes et al. · 2006 · BMC Infectious Diseases · 205 citations
Complications of Circumcision
Aaron Krill, Lane S. Palmer, Jeffrey S. Palmer · 2011 · The Scientific World JOURNAL · 173 citations
In the United States, circumcision is a commonly performed procedure. It is a relatively safe procedure with a low overall complication rate. Most complications are minor and can be managed easily....
Male Circumcision for HIV Prevention in High HIV Prevalence Settings: What Can Mathematical Modelling Contribute to Informed Decision Making?
Catherine Hankins · 2009 · PLoS Medicine · 156 citations
Experts from UNAIDS, WHO, and the South African Centre for Epidemiological Modelling report their review of mathematical models estimating the impact of male circumcision on HIV incidence in high H...
Reading Guide
Foundational Papers
Start with Auvert et al. (2005, ANRS 1265 trial, 2437 citations) for primary RCT efficacy evidence; Weiss et al. (2010, complications review) for safety profile; Westercamp & Bailey (2006) for sub-Saharan acceptability.
Recent Advances
Njeuhmeli et al. (2011, VMMC modeling, 324 citations) for scale-up economics; Mattson et al. (2008, Kisumu risk behavior) for no compensation findings; Hankins (2009) for decision-modeling review.
Core Methods
Randomized controlled trials with intent-to-treat analysis (Auvert 2005); prospective complication cohort studies (Bailey 2008); dynamic mathematical modeling of HIV incidence (Njeuhmeli 2011, Hankins 2009).
How PapersFlow Helps You Research Male Circumcision HIV Prevention Trials
Discover & Search
Research Agent uses searchPapers('ANRS 1265 trial') to retrieve Auvert et al. (2005, 2437 citations), then citationGraph reveals 500+ downstream modeling papers like Njeuhmeli et al. (2011). exaSearch('Kisumu circumcision RCT risk compensation') surfaces Mattson et al. (2008); findSimilarPapers expands to 50+ VMMC studies.
Analyze & Verify
Analysis Agent runs readPaperContent on Auvert et al. (2005) to extract hazard ratios, then verifyResponse(CoVe) cross-checks claims against Kisumu data. runPythonAnalysis with pandas computes meta-analysis of complication rates from Weiss et al. (2010) and Bailey (2008), graded via GRADE as high-quality evidence.
Synthesize & Write
Synthesis Agent detects gaps in risk compensation studies post-2011, flags contradictions between traditional vs. clinical complications. Writing Agent uses latexEditText for trial comparison tables, latexSyncCitations for 20-paper bibliography, latexCompile for policy brief; exportMermaid diagrams VMMC scale-up workflows.
Use Cases
"Run meta-analysis of complication rates across circumcision trials"
Research Agent → searchPapers('circumcision complications') → Analysis Agent → runPythonAnalysis(pandas forest plot of Weiss 2010 + Bailey 2008) → researcher gets CSV hazard ratios + GRADE scores.
"Write LaTeX review of ANRS and Kisumu HIV efficacy trials"
Research Agent → citationGraph(Auvert 2005) → Synthesis → gap detection → Writing Agent → latexEditText + latexSyncCitations(15 papers) + latexCompile → researcher gets PDF with figures.
"Find code for VMMC HIV modeling simulations"
Research Agent → paperExtractUrls(Njeuhmeli 2011) → Code Discovery → paperFindGithubRepo → githubRepoInspect → researcher gets Python simulators for cost-impact models.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers(50+ VMMC papers) → DeepScan(7-step complication meta-analysis with CoVe checkpoints) → structured report on ANRS/Kisumu evidence. Theorizer generates hypotheses on optimal circumcision age from Weiss et al. (2010) complication data. DeepScan verifies modeling assumptions in Hankins (2009).
Frequently Asked Questions
What defines Male Circumcision HIV Prevention Trials?
Randomized controlled trials like ANRS 1265 (Auvert et al., 2005) and Kisumu assessing circumcision's 50-60% efficacy against heterosexual HIV acquisition.
What methods were used in key trials?
ANRS 1265 randomized 3274 uncircumcised men to intervention/control with HIV testing at 3, 12, 24 months (Auvert et al., 2005). Kisumu RCT used intent-to-treat analysis for risk behavior (Mattson et al., 2008).
What are the most cited papers?
Auvert et al. (2005, 2437 citations, ANRS trial); Weiss et al. (2010, 380 citations, complications review); Westercamp & Bailey (2006, 376 citations, acceptability).
What open problems remain?
Long-term risk compensation monitoring, VMMC equity in low-acceptability areas, and integration with PrEP (addressed in post-2011 modeling gaps).
Research Urologic and reproductive health conditions with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Male Circumcision HIV Prevention Trials with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers